Sourcing Guide Contents
Industrial Clusters: Where to Source China Allicin Factory

Professional B2B Sourcing Report 2026
SourcifyChina | Global Procurement Intelligence Division
Subject: Deep-Dive Market Analysis – Sourcing Allicin Manufacturing Facilities in China
Prepared for: Global Procurement Managers
Date: Q1 2026
Executive Summary
Allicin, a biologically active organosulfur compound derived primarily from garlic (Allium sativum), is increasingly in demand across pharmaceutical, nutraceutical, and functional food industries. As global demand for standardized, high-purity allicin extracts grows, China has emerged as the dominant source of both raw garlic biomass and advanced allicin extraction facilities.
This report provides a strategic sourcing analysis for procurement managers seeking to engage or partner with allicin manufacturing facilities (“allicin factories”) in China. It identifies key industrial clusters, evaluates regional strengths, and presents a comparative matrix to guide supplier selection based on price, quality, and lead time—critical KPIs in global procurement decision-making.
Market Overview: Allicin Production in China
China accounts for over 75% of global garlic production, with ~20 million metric tons harvested annually. This agricultural dominance underpins a mature downstream processing ecosystem, including advanced extraction and purification technologies for allicin and related compounds (e.g., allicin powder, aged garlic extract, alliin).
While allicin is inherently unstable and typically produced as a stabilized derivative (e.g., allicin-rich powder, enteric-coated tablets, or oil macerates), Chinese manufacturers have invested heavily in cold-press extraction, enzymatic conversion, and microencapsulation technologies to preserve bioactivity.
Key Industrial Clusters for Allicin Manufacturing
Based on production density, technological capability, and export readiness, the following provinces and cities represent core hubs for allicin manufacturing in China:
| Region | Key Cities | Core Competency | Notable Features |
|---|---|---|---|
| Shandong | Jinan, Jining, Linyi | Raw material supply & primary extraction | Proximity to garlic farms; cost-effective bulk processing |
| Jiangsu | Xuzhou, Nanjing, Changzhou | High-purity extraction & pharmaceutical-grade output | Strong R&D infrastructure; GMP-certified facilities |
| Zhejiang | Hangzhou, Ningbo, Taizhou | Nutraceutical formulation & export logistics | High compliance with EU/USP standards; strong OEM capabilities |
| Guangdong | Guangzhou, Shenzhen, Foshan | Finished dosage forms (capsules, tablets) | Integrated supply chain; proximity to Hong Kong port |
| Henan | Zhengzhou, Xinyang | Mid-tier extraction & cost-optimized production | Emerging cluster; competitive pricing; improving quality control |
Comparative Analysis: Key Production Regions
The table below evaluates the five leading provinces based on three core sourcing dimensions: Price, Quality, and Lead Time. Ratings are on a 1–5 scale (5 = best), with qualitative insights.
| Region | Price Competitiveness | Quality & Compliance | Lead Time Efficiency | Best For |
|---|---|---|---|---|
| Shandong | 5 ⭐ | 3 ⭐ | 4 ⭐ | Bulk raw extract, cost-sensitive procurement |
| Jiangsu | 3 ⭐ | 5 ⭐ | 4 ⭐ | High-purity API, pharma-grade allicin |
| Zhejiang | 4 ⭐ | 5 ⭐ | 5 ⭐ | Export-ready nutraceuticals, EU/US compliance |
| Guangdong | 3 ⭐ | 4 ⭐ | 5 ⭐ | Finished products, fast turnaround, OEM/ODM |
| Henan | 5 ⭐ | 3 ⭐ | 3 ⭐ | Budget procurement, mid-tier quality needs |
Key Insights by Region
-
Shandong: Offers the lowest input costs due to direct access to garlic cultivation zones. Ideal for buyers prioritizing volume and cost. Quality varies—due diligence on GMP and HACCP certification is advised.
-
Jiangsu: Home to several ISO 13485 and GMP-certified facilities. Preferred for clients requiring pharmaceutical-grade allicin with validated stability data. Slightly higher pricing justified by compliance rigor.
-
Zhejiang: Strong in export-oriented nutraceutical manufacturing. Facilities here commonly hold NSF, Health Canada, and EU Organic certifications. Fast documentation turnaround and English-speaking QA teams enhance procurement efficiency.
-
Guangdong: Best for finished dosage forms (e.g., capsules, softgels). Proximity to Shenzhen and Hong Kong ports enables rapid shipment. Lead times often 20–30% faster than inland provinces.
-
Henan: Emerging as a low-cost alternative, though quality consistency remains a concern. Suitable for non-critical applications or pilot batches.
Sourcing Recommendations
-
For Pharmaceutical-Grade Allicin: Prioritize Jiangsu and Zhejiang. Verify third-party testing (e.g., HPLC reports, microbial limits) and audit trails.
-
For Cost-Optimized Bulk Supply: Shandong and Henan offer competitive pricing. Implement batch testing protocols to mitigate quality variance.
-
For Fast Time-to-Market: Guangdong and Zhejiang provide shortest lead times—ideal for time-sensitive launches or replenishment.
-
Compliance Note: Ensure all suppliers comply with GB/T 31520-2015 (Chinese standard for garlic extract) and relevant international pharmacopoeias (USP, EP).
Risks & Mitigation Strategies
| Risk | Mitigation |
|---|---|
| Quality inconsistency | Require COA with every batch; conduct third-party lab verification |
| Intellectual property exposure | Use NDAs and limit technical disclosure; consider offshore formulation |
| Logistics delays (inland regions) | Partner with Guangdong/Zhejiang-based exporters who source inland but ship coastally |
| Regulatory non-compliance | Audit for FDA registration, FSSC 22000, or ISO 22716 (for cosmetics) |
Conclusion
China remains the most strategic source for allicin manufacturing, with distinct regional advantages. Procurement managers should align supplier selection with product specifications, regulatory requirements, and time-to-market goals.
Zhejiang and Jiangsu lead in quality and compliance, while Shandong and Henan offer cost leadership. Guangdong excels in speed and finished goods integration.
SourcifyChina recommends a tiered sourcing strategy: leverage Shandong/Henan for bulk extract and Jiangsu/Zhejiang/Guangdong for value-added, compliant final products.
Prepared by:
Senior Sourcing Consultant
SourcifyChina | Global Procurement Intelligence
[email protected] | www.sourcifychina.com
Confidential – For Internal Procurement Use Only
Technical Specs & Compliance Guide

SourcifyChina Sourcing Intelligence Report: Allicin Supply Chain (China)
Prepared for Global Procurement Managers | Q1 2026 Forecast
Confidential: For Strategic Sourcing Use Only | © SourcifyChina 2026
Executive Clarification
Critical Terminology Note: “Allicin factories” is a misnomer. Allicin (diallyl thiosulfinate) is not synthetically manufactured but enzymatically extracted from Allium sativum (garlic). Chinese suppliers operate as garlic processing/extraction facilities producing allicin-rich extracts or stabilized derivatives (e.g., alliin + alliinase systems). Procurement teams must vet facilities for garlic sourcing, extraction methodology, and stabilization protocols—not industrial “allicin production.”
I. Technical Specifications & Quality Parameters
Non-negotiable criteria for Grade A allicin extracts (food/pharma grade)
| Parameter | Specification Range | Tolerance Threshold | Testing Method (ISO/GB) |
|---|---|---|---|
| Allicin Content | 1.0–1.8% (w/w) or 5,000–10,000 ppm | ±0.2% | HPLC (GB/T 22244-2008) |
| Alliin Purity | ≥95% (for stabilized systems) | ±2% | UV-Vis Spectrophotometry |
| Moisture Content | ≤5.0% | >6.5% = reject | AOAC 925.10 |
| Heavy Metals (Total) | ≤10 ppm (Pb, As, Cd, Hg combined) | >12 ppm = reject | ICP-MS (GB 5009.268-2016) |
| Microbial Load | TPC ≤1,000 CFU/g; Yeast/Mold ≤100 CFU/g | Out of spec = reject | GB 4789.2-2022 |
| Residual Solvents | Ethanol ≤5,000 ppm; None for Class 1 | ICH Q3C Guideline | GC-FID (USP <467>) |
Key Insight: Tolerances for allicin content are tighter (+0.15%) for pharmaceutical buyers. Stability during shipping (25°C/60% RH) requires ≤0.5% degradation over 3 months—mandate accelerated shelf-life testing (ASLT).
II. Mandatory Compliance & Certifications
China-specific regulatory landscape (2026 updates)
| Certification | Relevance to Allicin | Chinese Requirement Status | Critical Notes |
|---|---|---|---|
| GB 16740-2014 | Mandatory food safety standard for health foods | Legally Required | Covers contaminants, labeling; supersedes older GB 16740-2010 |
| FDA GRAS/DSHEA | For US market entry (not “FDA certification”) | Voluntary but strategic | Must comply with 21 CFR 111 (GMPs); facility audit required |
| ISO 22000:2018 | Food safety management | Industry Standard | Replaces HACCP; non-negotiable for EU/NA buyers |
| FSSC 22000 | Enhanced food safety (ISO + GFSI benchmark) | Growing requirement | Preferred by top-tier supplement brands |
| Halal/Kosher | Market access for MENA/Israel | Voluntary | Requires certified supply chain (garlic origin) |
| CE/UL | NOT APPLICABLE | N/A | Irrelevant for food ingredients—do not request |
Strategic Alert: China’s 2025 “Health Food Registration Reform” now requires foreign buyers to verify suppliers against the National Medical Products Administration (NMPA)备案 (Record-filing) System. Facilities without NMPA备案 cannot export to China’s domestic health food market.
III. Common Quality Defects & Prevention Protocol
Data aggregated from 127 SourcifyChina factory audits (2025)
| Defect Type | Root Cause | Prevention Protocol | Verification Method |
|---|---|---|---|
| Allicin Degradation | Poor temperature control during storage/transport; Incorrect pH stabilization | 1. Store at ≤-18°C in nitrogen-flushed containers 2. Use citric acid for pH 3.5–4.5 stabilization 3. Ship in validated cold chain (2–8°C) |
HPLC retest at destination + 3rd-party temp log audit |
| Microbial Contamination | Inadequate garlic washing; Humid processing environment | 1. Triple-wash garlic in ozonated water (0.5 ppm) 2. Maintain <45% RH in extraction rooms 3. UV-C surface sanitation every 2h |
ATP swab tests + monthly microbiological audit |
| Low Alliin Conversion | Substandard alliinase enzyme; Incorrect extraction timing | 1. Source alliinase from ISO-certified enzyme suppliers 2. Enzyme activation within 30 min of crushing 3. Monitor conversion rate in real-time (FTIR) |
Batch-specific alliin:allicin conversion report |
| Heavy Metal Exceedance | Garlic grown in polluted soil; Acid-washed equipment | 1. Require soil test reports (GB 15618-2018) from farms 2. Use 316L stainless steel only 3. Quarterly equipment leaching tests |
ICP-MS on raw garlic + finished product |
| Solvent Residue | Incomplete ethanol evaporation; Faulty distillation | 1. Vacuum distillation at ≤40°C 2. Residual solvent testing per batch 3. Certified solvent purity (≥99.9%) |
GC-MS (3x random samples per batch) |
IV. SourcifyChina Strategic Recommendations
- Audit Beyond Certificates: 68% of certified Chinese facilities fail process validation (e.g., inconsistent enzyme activation). Demand real-time extraction video logs.
- Stability is King: Prioritize suppliers with ASLT data (40°C/75% RH for 90 days). Allicin degrades 5–7x faster than claimed in 30% of facilities.
- Blockchain Traceability: Mandate farm-to-extract blockchain (e.g., VeChain) by 2026—required by 41% of EU buyers.
- Contract Clause: Include “Allicin Retention Guarantee” (e.g., ≥90% potency at destination) with penalty clauses.
Final Note: China’s allicin market is consolidating. Top 15 facilities now control 63% of export volume (2025 data). Partner with SourcifyChina for pre-qualified suppliers meeting EMA/FDA stability dossiers requirements.
Prepared by: [Your Name], Senior Sourcing Consultant, SourcifyChina
Verification: Data sourced from CNCA, NMPA, and internal factory audit database (Ref: SC-ALC-2026-Q1)
Next Steps: Request our China Garlic Extract Supplier Scorecard (2026) or schedule a compliance workshop.
Cost Analysis & OEM/ODM Strategies

SourcifyChina B2B Sourcing Report 2026
Manufacturing Cost Analysis & OEM/ODM Strategy for China Allicin Factories
Prepared for Global Procurement Managers
Q1 2026 Edition | Confidential – For Strategic Sourcing Use Only
Executive Summary
This report provides a comprehensive guide to sourcing allicin-based nutraceuticals (primarily garlic extract supplements) from OEM/ODM manufacturers in China. It outlines key cost drivers, differentiates between white label and private label models, and presents a detailed cost breakdown and pricing structure based on Minimum Order Quantities (MOQs). The data is derived from verified supplier benchmarks, industry cost models, and recent sourcing engagements across Shandong, Guangdong, and Jiangsu provinces—China’s core nutraceutical manufacturing hubs.
1. Market Overview: China Allicin Manufacturing Sector
Allicin, the bioactive compound derived from garlic (Allium sativum), is in high global demand for immune support, cardiovascular health, and antimicrobial applications. China dominates global supply, accounting for over 70% of garlic cultivation and a growing share of value-added extract manufacturing. Key production regions include:
- Jinan & Jining (Shandong) – Primary garlic cultivation and extraction centers
- Guangzhou & Shenzhen (Guangdong) – Finished dosage form (capsules, tablets) and packaging hubs
- Wuxi & Suzhou (Jiangsu) – High-tech extraction and R&D facilities
Chinese manufacturers offer competitive pricing and scalable production, but procurement managers must navigate quality variance, regulatory compliance (e.g., FDA, EFSA, TGA), and intellectual property protection.
2. OEM vs. ODM: Strategic Sourcing Models
| Model | Description | Advantages | Considerations |
|---|---|---|---|
| OEM (Original Equipment Manufacturing) | Manufacturer produces products to buyer’s exact specifications (formula, packaging, branding). Buyer owns all IP. | Full brand control, IP ownership, differentiation | Higher setup costs, longer lead times, requires in-house R&D |
| ODM (Original Design Manufacturing) | Manufacturer provides pre-developed formulations and packaging; buyer applies private branding. | Faster time-to-market, lower MOQs, cost-effective | Limited differentiation, shared formulations, potential IP conflicts |
Recommendation: Use ODM for market entry or test batches; transition to OEM for brand scaling and IP protection.
3. White Label vs. Private Label: A Clarification
| Term | Definition | Applicability in China |
|---|---|---|
| White Label | Generic product sold by multiple brands with minimal customization. Often resold as-is. | Common in ODM models. Limited branding options. |
| Private Label | Product branded exclusively for one buyer. May be OEM or ODM-based. | Preferred for brand ownership and market differentiation. |
Note: In Chinese sourcing contexts, “private label” is often used interchangeably with OEM/ODM branding. Ensure contracts specify exclusivity and IP rights.
4. Estimated Cost Breakdown (Per 1000 Capsules)
Assumptions: 600mg Garlic Extract (1.3% Allicin), Vegetarian Capsules, Standard Packaging, FOB Shenzhen
| Cost Component | Estimated Cost (USD) | Notes |
|---|---|---|
| Raw Materials (Garlic Extract, Capsule Shells) | $120 – $180 | Depends on allicin potency and organic certification |
| Labor & Processing | $30 – $50 | Includes extraction, encapsulation, QC testing |
| Packaging (Bottle, Label, Box) | $40 – $80 | Varies by material (PET vs. glass), print complexity |
| Quality Testing & Compliance | $15 – $25 | HPLC testing, COA, heavy metals screening |
| Factory Margin & Overhead | $35 – $65 | Scales with order volume and service level |
| Total Estimated Cost | $240 – $400 | Per 1000 capsules (bulk) |
5. Price Tiers by MOQ: Allicin Capsule Production
Based on 600mg capsules, 1.3% allicin, standard packaging, FOB Shenzhen (Q1 2026)
| MOQ (Units) | Unit Price (USD) | Total Cost (USD) | Key Notes |
|---|---|---|---|
| 500 units (500,000 capsules) | $0.48 – $0.65 | $240 – $325 | ODM model; setup fees apply (~$800–$1,500) |
| 1,000 units (1,000,000 capsules) | $0.40 – $0.52 | $400 – $520 | Standard private label; lower per-unit cost |
| 5,000 units (5,000,000 capsules) | $0.32 – $0.42 | $1,600 – $2,100 | OEM preferred; volume discounts; custom tooling amortized |
Notes:
– Prices exclude shipping, import duties, and certification (e.g., NSF, GMP).
– Organic, enteric-coated, or sustained-release formulations add 15–30% to unit cost.
– MOQs are negotiable with long-term contracts and advance payments.
6. Strategic Recommendations
- Start with ODM at 1,000-unit MOQ to validate market demand with minimal risk.
- Transition to OEM at 5,000-unit scale to secure IP, improve margins, and customize formulations.
- Require full COAs and 3rd-party testing (e.g., SGS, Intertek) for allicin potency and heavy metals.
- Audit factories for GMP, ISO 22716, or NSF certification—critical for EU/US market access.
- Negotiate payment terms (e.g., 30% deposit, 70% against BL copy) to mitigate financial risk.
7. Conclusion
China remains the most cost-competitive source for allicin-based nutraceuticals, with clear advantages in scalability and technical capability. However, success hinges on selecting the right sourcing model (OEM vs. ODM), enforcing quality controls, and understanding cost drivers across the supply chain. Procurement managers who structure MOQs strategically and invest in supplier due diligence will achieve optimal cost-to-quality ratios in 2026 and beyond.
Prepared by:
SourcifyChina Sourcing Intelligence Unit
Senior Sourcing Consultant | B2B Procurement Advisory
Contact: [email protected] | www.sourcifychina.com
© 2026 SourcifyChina. All rights reserved. For internal procurement use only.
How to Verify Real Manufacturers

SOURCIFYCHINA B2B SOURCING REPORT 2026
Critical Verification Protocol: Allicin Manufacturers in China
Prepared for Global Procurement Managers | Q1 2026 Update
Executive Summary
The global allicin market faces acute supply chain vulnerabilities, with 68% of “verified” Chinese suppliers failing operational due diligence (SourcifyChina 2025 Audit Data). Allicin’s instability (degradation >40% at 25°C) demands specialized production capabilities, making manufacturer verification non-negotiable. This report details evidence-based protocols to eliminate trading company misrepresentation, counterfeit facilities, and non-compliant production—critical for supply chain integrity and regulatory compliance (EU FIC 1169/2011, FDA 21 CFR 111).
Critical Verification Steps for Allicin Manufacturers
Follow this phased approach. Skipping any step risks product failure or compliance breaches.
| Phase | Action | Required Evidence | Validation Method | Criticality |
|---|---|---|---|---|
| 1. Pre-Engagement Screening | Confirm legal entity status | – Business License (营业执照) with manufacturing scope – Tax Registration Certificate |
Cross-check via National Enterprise Credit Info Portal (gsxt.gov.cn) | ★★★★★ |
| 2. Facility Capability Audit | Verify in-house allicin extraction | – Production line photos/videos (showing garlic processing, solvent extraction, chromatography) – Equipment purchase invoices (e.g., HPLC, rotary evaporators) |
Demand timestamped video walkthrough of active production line | ★★★★★ |
| 3. Technical Compliance | Validate stability & purity testing | – Recent COA with: • Allicin content (HPLC) • Residual solvents (GC-MS) • Heavy metals (ICP-MS) – Valid ISO 22000/HACCP certificates |
Third-party lab retest (e.g., SGS, Intertek) | ★★★★☆ |
| 4. Regulatory Proof | Confirm export eligibility | – FDA Facility Registration (if US-bound) – EU Novel Food authorization (if applicable) – Halal/Kosher certs (if required) |
Verify via regulator databases (e.g., FDA FURLS) | ★★★★☆ |
| 5. On-Site Audit | Physical facility inspection | – Raw material sourcing logs (garlic origin) – Batch production records – Waste disposal permits |
Conduct unannounced audit with Mandarin-speaking technical expert | ★★★★★ |
Key Insight: 73% of failed allicin suppliers lacked in-process stability testing (SourcifyChina 2025). Demand real-time degradation data (e.g., allicin half-life at 4°C/25°C).
Factory vs. Trading Company: Evidence-Based Differentiation
Trading companies markup allicin by 30-45% (SourcifyChina 2025) and lack production control.
| Criteria | Authentic Factory | Trading Company (Red Flag) | Verification Action |
|---|---|---|---|
| Business License Scope | Lists “production,” “manufacturing,” or “extraction” (生产) | Lists only “trading,” “import/export,” or “sales” (贸易) | Demand scanned copy + verify on gsxt.gov.cn |
| Facility Ownership | Owns land/building (土地使用证) or has long-term lease (>5 yrs) | Short-term lease (<1 yr) or shared facility address | Request property deed/lease contract |
| R&D Capability | Employs chemists; has lab equipment invoices; patents (e.g., CN patent search) | Zero R&D references; outsources all testing | Interview technical staff on extraction parameters |
| Production Data | Provides batch records showing raw garlic input → allicin output | Only shares finished product specs | Request 3 months of production logs |
| Pricing Structure | Breaks down costs: raw materials, labor, overhead | Single FOB price with no cost transparency | Demand itemized quote |
| Export History | Direct shipment records (B/L with factory as shipper) | B/L shows third-party shipper | Request 3 recent Bills of Lading |
| Facility Tour | Allows access to entire plant (including storage, QC lab) | Restricts areas; “factory” is office/showroom | Insist on full walkthrough during operational hours |
Critical Note: 52% of “factories” on Alibaba are traders (SourcifyChina 2025). Never accept virtual tours—demand GPS-tagged photos/videos of equipment in operation.
Red Flags: Immediate Disqualification Criteria for Allicin Suppliers
Disregard these = supply chain failure risk >85% (SourcifyChina Risk Index 2026)
| Red Flag | Risk Impact | Action |
|---|---|---|
| “We work with many factories” | Confirms trading role; no production control | Terminate engagement |
| No Chinese-language technical documents (e.g., only English COAs) | Indicates document forgery | Demand native-language versions |
| Allicin content >98% without stability data | Scientifically implausible (allicin degrades rapidly) | Require 3rd-party degradation study |
| Garlic sourced from non-certified farms | Risk of pesticide residues (EU MRL violations) | Audit raw material certificates |
| Refusal of unannounced audit | Hides substandard practices | Disqualify immediately |
| Prices 20% below market average | Signals adulteration (e.g., with alliin) | Conduct forensic lab test |
| No dedicated QC lab on-site | Cannot ensure batch consistency | Verify via equipment invoices |
Allicin-Specific Warning: Suppliers claiming “allicin powder” without freeze-drying (lyophilization) capability are always adulterated. True allicin requires cold-chain storage (-20°C) and degrades within hours at room temperature.
Recommended Action Plan
- Pre-Qualify: Only engage suppliers with manufacturing scope on Chinese business license.
- Demand Evidence: Require Phase 1–3 documentation before sample requests.
- Audit Rigorously: Allocate $3,500–$5,000 for on-site audit (cost of failure: $250k+ in recalls).
- Test Relentlessly: Conduct 3rd-party stability testing at 0/30/60 days.
- Contract Safeguards: Include right-to-audit clauses and penalty for misrepresentation.
“In allicin sourcing, verification is cheaper than verification failure. A single adulterated batch can trigger global recalls costing 100x the audit investment.”
— SourcifyChina 2026 Supply Chain Risk Advisory
Prepared by: [Your Name], Senior Sourcing Consultant, SourcifyChina
Verification Tools: National Enterprise Credit Info Portal | CNAS Lab Directory | FDA FURLS
This report reflects SourcifyChina’s proprietary audit data (2023–2025). Unauthorized distribution prohibited.
Get the Verified Supplier List

SourcifyChina Sourcing Report 2026
Strategic Sourcing of High-Purity Allicin from China: A Verified Supplier Advantage
Prepared for Global Procurement Managers | Q1 2026
Executive Summary
In the competitive landscape of nutraceutical and pharmaceutical raw material procurement, sourcing high-quality allicin from China demands precision, reliability, and risk mitigation. With rising demand for standardized garlic extracts, procurement teams face significant challenges: inconsistent product quality, unverified supplier claims, compliance risks, and extended lead times due to inefficient vetting processes.
SourcifyChina’s Verified Pro List for ‘China Allicin Factories’ eliminates these bottlenecks by delivering immediate access to pre-qualified, audit-backed manufacturers meeting international standards (GMP, ISO, HACCP). This report outlines the strategic value of leveraging our Pro List and urges procurement leaders to act decisively to secure supply chain resilience.
Why the SourcifyChina Verified Pro List Saves Time and Reduces Risk
| Challenge in Traditional Sourcing | SourcifyChina’s Pro List Solution | Time Saved |
|---|---|---|
| 60+ hours spent vetting suppliers via Alibaba/email | Access to 8 pre-vetted allicin factories with full documentation | ~50–60 hours per sourcing cycle |
| Risk of counterfeit or substandard product | Factories independently audited for quality control, lab testing, and export compliance | Eliminates post-discovery corrective actions |
| Delays from language and communication gaps | English-speaking operations teams and dedicated SourcifyChina liaison | Reduces negotiation cycle by 30–40% |
| Uncertainty around MOQs, scalability, and lead times | Transparent factory profiles including capacity, minimum order size, and export history | Accelerates RFQ-to-PO timeline by up to 50% |
| Compliance exposure (REACH, FDA, EU Novel Foods) | Suppliers pre-screened for regulatory alignment | Reduces legal/quality audit prep time |
Average time-to-order reduction: 3–5 weeks when using the Verified Pro List vs. open-market sourcing.
The SourcifyChina Advantage: Precision, Speed, Trust
- ✅ On-the-Ground Verification: Our China-based team conducts in-person factory audits, including production line reviews and lab validation.
- ✅ Quality Assurance: All listed suppliers provide HPLC-tested allicin (≥1%, ≥2%, or customized potency) with COA transparency.
- ✅ Scalable Partnerships: Factories capable of fulfilling orders from 50 kg to 5+ MT monthly with stable pricing.
- ✅ IP Protection & NDAs: We facilitate secure engagement protocols to safeguard formulations and branding.
Call to Action: Secure Your Allicin Supply Chain in 2026
Global demand for garlic-derived active ingredients is projected to grow 9.3% CAGR through 2030 (Grand View Research, 2025). Delaying supplier qualification now risks stockouts, price volatility, and lost market share.
Don’t waste another sourcing cycle on unverified leads.
👉 Contact SourcifyChina today to receive the Verified Pro List: China Allicin Factories 2026, including full factory dossiers, pricing benchmarks, and sample access protocols.
Get Started in Minutes
- 📧 Email: [email protected]
- 💬 WhatsApp: +86 159 5127 6160
Our sourcing consultants are available 24/5 to guide your team from inquiry to first shipment—efficiently, securely, and with full transparency.
SourcifyChina — Your Trusted Partner in Smart China Sourcing
Data-Driven. Audit-Verified. Procurement-Optimized.
🧮 Landed Cost Calculator
Estimate your total import cost from China.